EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/78716
130 EW MEETING REPORTER March 2012 Reporting live from the 2012 ASCRS Winter Update meeting, Riviera Maya, Mexico Viisit E eKon ASCRS- CS Liegner said he injects triamcinolone and moxifloxacin into the zonules. "It nearly removes the requirement for pre-operative and post-operative eye drops," Dr. Liegner said, adding that the shot suppresses inflamma- tion about 94% of the time. The other 6% of patients receive an addi- tional supplement of Pred Forte (prednisolone, Allergan). "I have had no infections after 400 cases," Dr. Liegner said. He said the shot eliminates the "incredible amount of sit EyeKon | ASCR - Ch cagohici ago | A p l 20-24, 2012 PMMA IOL PMMA IOL FDA ppr FDA AApproved crrylic intraocular Hydrophilic drophilic Hy dropho Capsu ar Teapsular Tl Viscoelastics isc elastics HPMC | HPMC PLLUS SH We offer a broad range of volumes and concentrations based on your requirements! US | SH| drophobic ensioni Tens on Riings ngs ed!! Ac ylic intraocular lenses available in Natu al Ye turral Ye lo ellol w drop anxiety" his patients face. "There's a tremendous inertia, an avoidance," he said. Dr. Liegner plans to present his yearlong data at the 2012 ASCRS•ASOA Symposium & Congress in Chicago in April. An update on crosslinking Crosslinking remains a hot topic in ophthalmology. R. Doyle Stulting, M.D., Woolfson Eye Institute, Atlanta, presented an overview of the technology in the day's last prriil 20-24,2012 | | B oth 1907Booth 190 7 session. The technology is not yet available in the U.S., despite 10 years of research proving its effectiveness in stiffening the cornea for kerato- conic and ectatic patients, Dr. Stulting said. "This is a disease that has no treatment; crosslinking is something that we can offer our patients that will give them a life- time of good vision and avoiding transplants," he said. Currently, researchers are studying how to shorten the exposure times and are looking at iontophoresis devices to distribute the riboflavin, Dr. Stulting said. He expects crosslinking to be approved in the U.S. in the next year and continues to have high hopes for its usefulness. "We can eradicate a disease with very few ramifica- tions," Dr. Stulting said. Dr. Chan added that patients with autism and Down syndrome have been able to benefit from crosslinking technol- ogy as well. EW ReVive Your Eyes Daily Moist Hydrating Cloths TM Editors' note: Dr. Bakewell has finan- cial interests with Abbott Medical Optics (Santa Ana, Calif.). Dr. Banja has no financial interests related to his talks. Dr. Chan has no financial inter- ests related to her comments. Dr. Chang has no financial interests related to his talk. Dr. de Luise has no financial interests related to his talks. Dr. Donnenfeld has financial interests with Alcon (LenSx, Fort Worth, Texas), Allergan, Abbott Medical Optics, Bausch + Lomb (Rochester, N.Y.), Inspire Pharmaceuticals (Durham, N.C.), LensAR (Winter Park, Fla.), OptiMedica Corp. (Santa Clara, Calif.), and Technolas (St. Louis). Dr. Kim has financial interests with ISTA (Irvine, Calif.), Alcon, and Allergan (Irvine, Calif.). Dr. Lane has financial interests with Alcon, SMI (Teltow, Germany), and WaveTec. Dr. Lewis has financial interests with Alcon, Allergan, and Glaukos. Dr. Liegner has no financial interests related to his talk. Dr. Rubenstein has no financial interests related to his talk. Dr. Samuelson has financial interests with AMO, Alcon, Allergan, and Merck (Whitehouse Sta- tion, N.J.). Dr. Stulting has no financial interests related to his talk. Dr. Warren has financial interests with Alcon. ReVive Your Eyes pillow-soft pads whisk away irritants such as pollen and dust while removing oils & debris that cause eye irritation. EyeKon's moist cleansing cloths provide a cool rush of hydration & moisture while promoting proper hygiene. Also effectively removes costemtics. Gentle formula soothes sensitive Eyelids & Lashes! TM EEye Ko Made n USA Cllear 727 793.0170 ww e ekonmedical.com Ange a@eye onmedical.com Sh r ey@e ekonmedical com 727.793.0170. ade in USAi gela@el wwww..eyekonmedical.com ekkonmedical.com hiri lley@eyekonmedical..com earwater, err,Fllor da oriida yeKonn EyeCoat SH New Product!